Trial to start for new heart attack drug
A potential new drug to improve the long-term outcomes for heart attack patients will be…
November 23, 2022 - 3 minutes
Cardiovascular disease
How cardioids can usher in the next generation of drug discovery
The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s…
November 18, 2022 - 6 minutes
Sequana Medical has positive results for heart failure therapy drug
Sequana Medical has had some very positive top-line results from a phase 2a study, that…
November 15, 2022 - 3 minutes
Proteins identified by FunSel and developed by Forcefield can preserve heart function
Forcefield Therapeutics, has presented positive preclinical data on three proteins identified by it FunSel platform…
November 7, 2022 - 3 minutes
The biggest private biotech investments in September 2022
The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022,…
October 11, 2022 - 3 minutes
Novartis Biome UK Heart Health Catalyst 2022 winners announced
Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful…
October 6, 2022 - 2 minutes
Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders
Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led…
September 22, 2022 - 3 minutes
Cuffless device worn 24/7 can lower blood pressure, says Aktiia
A company making cuffless monitors for blood pressure says a significant and sustained reduction has…
September 12, 2022 - 2 minutes
Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary
Artificial intelligence (AI) stroke imaging will be deployed across centers in Hungary after Brainomix was…
September 1, 2022 - 4 minutes
Vaderis emerges from stealth to start HTT trial
Vaderis Therapeutics AG, a clinical stage biotech company focused on developing treatments for rare diseases…
August 22, 2022 - 3 minutes
Sanofi sells two portfolios of established products to Neuraxpharma
Two drugs portfolios with products to treat the central nervous system, pain and vascular disease…
July 13, 2022 - 2 minutes
Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a…
July 5, 2022 - 4 minutes
